RGCC Group

We are leading experts in the field of cancer genetics and chemosensitivity tests. We have been working with GPs and doctors all over the world since 2004 to provide the most up-to-date cancer detection and chemosensitivity tests available.

We aim to detect any potential early signs of cancer, monitor any existing cancers and produce a personalised profile of chemotherapy drugs and natural treatments that could benefit individual patients.

We can work directly with you or your doctor to carry out a liquid biopsy. We will analyse your blood samples and identify information that can be potentially useful for identifying and diagnosing certain types of cancer.

In addition to being a diagnostic tool, liquid biopsy tests can be useful in monitoring the progress of the disease. The results of our tests can provide doctors with additional insights to support the development of personalised patient treatment plans.

All of our tests are carried out at our ISO-accredited laboratories, which are equipped with the latest technology and specialised software for data analysis.

Patient info leaflet

Patient information

Need help?

Will you send me the results directly?

Do I need to go through my GP to get a test?

Can RGCC test for BRAF drugs?

Can the Oncotrace test differentiate between benign and malignant tumour cells?

I have a patient whose specific tumour appears to have resisting populations because of the overexpression of the MDR1 gene. This can be reversed by the use of inhibitors of ABG2 pumps. What do I do?

Global Presence